A monthly video conference series about how you and LLS are advancing blood cancer research in the quest for cures.
With hosts Drs. Lou DeGennaro, Gwen Nichols and Lee Greenberger
Risks and Responses: COVID-19 Vaccines and Blood Cancer Patients
Tuesday, March 30 at 1:00 PM (ET)
With the distribution of the COVID-19 vaccines gaining ground across the country come many pressing concerns for blood cancer patients. How effective are these vaccines for immunocompromised patients? Who is most at risk even with the vaccine? What dangers do the emerging COVID-19 variants pose to blood cancer patients and survivors? The pandemic’s rapid spread has meant that too little is yet known about the impact of COVID-19 on blood cancer patients, but there is research underway to understand risks and responses to the virus and the vaccines. Join us for an important LLS Research Now panel as Drs. Gwen Nichols and Lee Greenberger host medical leaders at the front lines of this dynamic area of inquiry.
Irene Ghobrial, MD (Dana-Farber Cancer Institute) is an expert in multiple myeloma and Waldenstrom's macroglobulinemia, and is conducting research in novel therapeutic agents for these blood cancers. She will speak to the implications of COVID-19 for these patients.
Piers Patten, MB, PhD (King’s College Hospital, UK) is a UK trained hematologist with expertise in chronic lymphocytic leukemia. He will join us from his practice in the UK to share the very latest on the pandemic‘s course, the latest variants and vaccine science, with an additional focus on the needs of leukemia patients. Recently, Dr. Patten co-authored a groundbreaking paper in a high-profile journal on the immune response of patients receiving the COVID-19 vaccine.
Steve Rosen, MD (City of Hope Cancer Research Center) is provost and chief scientific officer for City of Hope in Southern California, which recently opened a new COVID vaccine trial for healthy patients. A prominent lymphoma researcher, he will share important insights on the needs of patients with lymphoma.
2021 Tentative Topics:
April: IMPACT Grant Program
May: An Update on LLS Children's Initiative
June: ASCO Annual Meeting & Clinical Progress
July: Stop MDS and Beat AML
January 2021: Recent Advances and New Opportunities in Blood Cancer Research and Treatment (video here)
November 2020: Blood Cancer Prevention & Survivorship (video here)
October 2020: LLS's Venture Philanthropy Model for Accelerating Promising Therapies (video here)
September 2020: The Remarkable Promise of Immunotherapy (video here)
August 2020: Research at the Intersection of COVID-19 and Blood Cancer (video here)
July 2020: A Panel Discussion on the Career Development Program (video here)